No Picture
Trading Ideas

AstraZeneca-Merck Lynparza Prostate Cancer Treatment Gets FDA Approval

AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced prostate cancer.The FDA approval was awarded following results from a Phase III trial, which found that the Lynparza drug treatment reduced the risk of disease progression or death by 66%.Prostate cancer is the second-most common cancer type in men and despite an increase in the number of available therapies for men suffering from the disease, five-year survival remains low.Lynparza is a first-in-class PARP inhibitor, which is a targeted treatment to potentially …read more […]

No Picture
Trading Ideas

Oil up on lower U.S. stocks, firmer demand

Oil prices firmed on Wednesday on signs of improving demand and a drawdown in U.S. crude inventories, but worries over the economic fallout from the coronavirus pandemic and weak refining margins capped gains. Brent crude futures were up 51 cents, or 1.47%, at $35.16 per barrel at 0928 GMT. U.S. West Texas Intermediate (WTI) July crude futures were up 22 cents, or 0.69%, at $32.18 a barrel. …read more […]

No Picture
Trading Ideas

TikTok Owner’s Value Surpasses $100 Billion

(Bloomberg) — ByteDance Ltd.’s valuation has risen at least a third to more than $100 billion in recent private share transactions, people familiar with the matter said, reflecting expectations the owner of video phenom TikTok will keep pulling in advertisers despite the Covid-19 pandemic.Stock in the world’s most valuable startup has changed hands recently at a price that suggests its value has risen more than 33% from about $75 billion during a major round of funding two years ago, the people said, requesting not to be named because the issue isn’t public. Some of those transactions valued the Chinese company …read more […]

No Picture
Trading Ideas

Nasdaq's China Crackdown Looks Halfhearted

(Bloomberg Opinion) — Nasdaq is tightening rules on initial public offerings in an effort that looks to be targeted primarily at Chinese companies. To appreciate just how tepid its proposals are, consider this: They wouldn’t have screened out Luckin Coffee Inc., the most notorious accounting scandal involving a U.S.-listed Chinese issuer in years. On this evidence, IPO hopefuls have little to worry about — as long as they’re not too small.Companies will need to raise at least $25 million, or sell stock equal to a minimum 25% of their post-listing market capitalization, according to a Bloomberg News report that cited …read more […]